Cargando…

New ex vivo demyelination/remyelination models to defeat multiple sclerosis and neuromyelitis optica

Detalles Bibliográficos
Autor principal:	Liu, Yiting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585544/ https://www.ncbi.nlm.nih.gov/pubmed/31169186 http://dx.doi.org/10.4103/1673-5374.257525

Ejemplares similares

Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
por: Deeb, Khaled, et al.
Publicado: (2019)

Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis
por: Anastasiadou, Sofia, et al.
Publicado: (2015)

Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
por: Rodney, Cady, et al.
Publicado: (2020)

Clobetasol promotes remyelination in a mouse model of neuromyelitis optica
por: Yao, Xiaoming, et al.
Publicado: (2016)

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases
por: Yokote, Hiroaki, et al.
Publicado: (2016)

Tenascins Interfere With Remyelination in an Ex Vivo Cerebellar Explant Model of Demyelination
por: Bauch, Juliane, et al.
Publicado: (2022)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Neuromyelitis Optica Spectrum Disorder with Tumefactive Demyelination mimicking Multiple Sclerosis: A Rare Case
por: Roy, Ujjawal, et al.
Publicado: (2016)

Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum
por: Ortiz, Genaro Gabriel, et al.
Publicado: (2023)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
por: Unni, Narayanan, et al.
Publicado: (2013)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016)

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021)

In Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination
por: Merrill, Jean E
Publicado: (2008)

Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update
por: Noval, Susana, et al.
Publicado: (2011)

Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica
por: Etemadifar, Masoud, et al.
Publicado: (2014)

Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica
por: Shin, Joon Sung, et al.
Publicado: (2019)

The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
por: Moayednia, Milad, et al.
Publicado: (2021)

The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Lopez, Joseph A, et al.
Publicado: (2021)

Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Chen, Hai, et al.
Publicado: (2016)

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
por: Cree, Bruce AC, et al.
Publicado: (2015)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

AZD-1222: New relapse of multiple sclerosis and neuromyelitis optica: 9 case reports
Publicado: (2022)

Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020)

Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
por: Pudlac, Adam, et al.
Publicado: (2020)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Arslan, Burak, et al.
Publicado: (2021)

Jaw clonus in neuromyelitis optica spectrum disorder with subsequent osmotic demyelination syndrome
por: Ghosh, Ritwik, et al.
Publicado: (2020)

Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Elasomeran/tozinameran: Multiple sclerosis, exacerbation of multiple sclerosis and neuromyelitis optica: 7 case reports
Publicado: (2022)

A New Model of Cuprizone-Mediated Demyelination/Remyelination
por: Sachs, Hilary H., et al.
Publicado: (2014)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
por: Vabanesi, Marco, et al.
Publicado: (2019)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Sun, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aci8o3s9jbcajm9ghobart9ca8